Get startedLog in
    Picture of Corbus Pharmaceuticals Holdings logo

    CRBP — Corbus Pharmaceuticals Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Corbus Pharmaceuticals Announces FDA Clearance Of Ind Application For Its Anti-Αvβ8 Monoclonal Antibody (Crb-601)

    Picture of Corbus Pharmaceuticals Holdings logoCorbus Pharmaceuticals Holdings
    09/01/2024 14:20
    Jan 9 (Reuters) - Corbus Pharmaceuticals Holdings Inc
 CRBP.O :
    * CORBUS PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND
APPLICATION FOR ITS ANTI-ΑVΒ8 MONOCLONAL ANTIBODY (CRB-601)
    * PHASE 1 CLINICAL STUDY SET TO COMMENCE H1 2024
    * PHASE 1 CLINICAL STUDY SET TO COMMENCE H1 2024

Source text for Eikon:  ID:nGNX4JgTjs 
Further company coverage:  CRBP.O 

 (Reporting by Vallari Srivastava)
 ((Srivastava.Vallari@thomsonreuters.com;))

    Recent news on Corbus Pharmaceuticals Holdings

    See all news